GrowingStockReport.com

NASDAQ Gainers Watch List: Novavax, Inc. (NASDAQ:NVAX) and PDL BioPharma, Inc. (NASDAQ:PDLI) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/06/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Novavax, Inc. (NASDAQ:NVAX) and PDL BioPharma, Inc. (NASDAQ:PDLI).

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company that focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases is currently up (+3.96%) on 6,386,090 shares traded after Novavax's CEO Presented at Piper Jaffray HC 2013 Conference. Novavax, Inc. (NASDAQ:NVAX) is currently up (+158.33%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Novavax, Inc. (NASDAQ:NVAX)

PDL BioPharma, Inc. (NASDAQ:PDLI) a company that engages in intellectual property asset management and patent portfolio and related assets investment activities is currently up (+1.91%) on 2,346,267 shares traded after PDL BioPharma Announced Conversion Rate Adjustments for Convertible Notes. PDL BioPharma, Inc. (NASDAQ:PDLI) is currently up (+29.23%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about PDL BioPharma, Inc. (NASDAQ:PDLI)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com